Official SEC submissions
ABVC BioPharma SEC Filings
Direct answer
ABVC BioPharma's latest SEC filing is 8-K.
Get free ABVC BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Recent SEC filings
DEF 14A
Proxy statement
Filed:
Report date:
DEFINITIVE PROXY STATEMENT
10-Q/A
Periodic report
Filed:
Report date:
AMENDMENT NO. 1 TO FORM 10-Q
8-K/A
Current report
Filed:
Report date:
AMENDMENT NO. 1 TO FORM 8-K
8-K/A
Current report
Filed:
Report date:
AMENDMENT NO. 1 TO FORM 8-K
8-K/A
Current report
Filed:
Report date:
AMENDMENT NO. 1 TO FORM 8-K
DEF 14A
Proxy statement
Filed:
Report date:
DEFINITIVE PROXY STATEMENT
8-K/A
Current report
Filed:
Report date:
AMENDMENT NO. 2 TO FORM 8-K
8-K/A
Current report
Filed:
Report date:
AMENDMENT NO. 1 TO FORM 8-K
8-K/A
Current report
Filed:
Report date:
AMENDMENT NO. 1 TO FORM 8-K
SC 13G/A
Ownership report
Filed:
Verified data
- Recent filing categories
- 4
- Recent filings
- 40
- SEC CIK
- 0001173313
- Latest filing date
- August 27, 2026